• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭患者合并或不合并孤立性或混合性二尖瓣和三尖瓣反流的患病率、临床特征和结局:来自 ESC-HFA 心力衰竭长期注册研究的分析。

Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term Registry.

机构信息

Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', University of Medicine Carol Davila, Bucharest, Romania.

出版信息

Eur J Heart Fail. 2023 Jul;25(7):1061-1071. doi: 10.1002/ejhf.2929. Epub 2023 Jun 26.

DOI:10.1002/ejhf.2929
PMID:37365841
Abstract

AIM

Mitral regurgitation (MR) and tricuspid regurgitation (TR) are common in patients with heart failure (HF). The aim of this study was to investigate prevalence, clinical characteristics and outcomes of patients with or without isolated or combined MR and TR across the entire HF spectrum.

METHODS AND RESULTS

The ESC-HFA EORP HF Long-Term Registry is a prospective, multicentre, observational study including patients with HF and 1-year follow-up data. Outpatients without aortic valve disease were included and stratified according to isolated or combined moderate/severe MR and TR. Among 11 298 patients, 7541 (67%) had no MR/TR, 1931 (17%) isolated MR, 616 (5.5%) isolated TR and 1210 (11%) combined MR/TR. Baseline characteristics were differently distributed across MR/TR categories. Compared to HF with reduced ejection fraction, HF with mildly reduced ejection fraction was associated with a lower risk of isolated MR (odds ratio [OR] 0.69; 95% confidence interval [CI] 0.60-0.80), and distinctly lower risk of combined MR/TR (OR 0.51; 95% CI 0.41-0.62). HF with preserved ejection fraction (HFpEF) was associated with a distinctly lower risk of isolated MR (OR 0.42; 95% CI 0.36-0.49), and combined MR/TR (OR 0.59; 95% 0.50-0.70), but a distinctly increased risk of isolated TR (OR 1.94; 95% CI 1.61-2.33). All-cause death, cardiovascular death, HF hospitalization and combined outcomes occurred more frequently in combined MR/TR, isolated TR and isolated MR versus no MR/TR. The highest incident rates were observed in isolated TR and combined MR/TR.

CONCLUSION

In a large cohort of outpatients with HF, prevalence of isolated and combined MR and TR was relatively high. Isolated TR was driven by HFpEF and was burdened by an unexpectedly poor outcome.

摘要

目的

二尖瓣反流(MR)和三尖瓣反流(TR)在心力衰竭(HF)患者中较为常见。本研究旨在调查整个 HF 谱中单纯或联合 MR 和 TR 的患者的患病率、临床特征和结局。

方法和结果

ESC-HFA EORP HF 长期注册研究是一项前瞻性、多中心、观察性研究,纳入 HF 患者并随访 1 年。排除主动脉瓣疾病患者,并根据单纯或联合中重度 MR 和 TR 进行分层。在 11298 例患者中,7541 例(67%)无 MR/TR,1931 例(17%)单纯 MR,616 例(5.5%)单纯 TR,1210 例(11%)联合 MR/TR。基线特征在 MR/TR 分类中分布不同。与射血分数降低性 HF 相比,射血分数轻度降低性 HF 与单纯性 MR 的风险降低相关(比值比 [OR] 0.69;95%置信区间 [CI] 0.60-0.80),且联合性 MR/TR 的风险明显降低(OR 0.51;95% CI 0.41-0.62)。射血分数保留性 HF(HFpEF)与单纯性 MR(OR 0.42;95% CI 0.36-0.49)和联合性 MR/TR(OR 0.59;95% CI 0.50-0.70)的风险明显降低,但单纯性 TR 的风险明显增加(OR 1.94;95% CI 1.61-2.33)。所有原因死亡、心血管死亡、HF 住院和联合结局在联合性 MR/TR、单纯性 TR 和单纯性 MR 中比无 MR/TR 更常见。单纯性 TR 和联合性 MR/TR 的发生率最高。

结论

在 HF 门诊患者的大样本中,单纯性和联合性 MR 和 TR 的患病率相对较高。单纯性 TR 由 HFpEF 驱动,且预后出乎意料地差。

相似文献

1
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term Registry.射血分数保留的心力衰竭患者合并或不合并孤立性或混合性二尖瓣和三尖瓣反流的患病率、临床特征和结局:来自 ESC-HFA 心力衰竭长期注册研究的分析。
Eur J Heart Fail. 2023 Jul;25(7):1061-1071. doi: 10.1002/ejhf.2929. Epub 2023 Jun 26.
2
Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry.射血分数降低、轻度降低和保留的心衰患者中主动脉瓣疾病的患病率、特征和预后影响:ESC 心衰长期注册研究分析。
Eur J Heart Fail. 2023 Jul;25(7):1049-1060. doi: 10.1002/ejhf.2908. Epub 2023 Jun 6.
3
Tricuspid regurgitation in elderly patients with acute heart failure: insights from the KCHF registry.老年急性心力衰竭患者的三尖瓣反流:来自 KCHF 注册研究的见解。
ESC Heart Fail. 2023 Jun;10(3):1948-1960. doi: 10.1002/ehf2.14348. Epub 2023 Mar 29.
4
Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients.尽管在房颤患者中左心室射血分数正常,但功能性二尖瓣和三尖瓣反流的患病率及其预后意义。
Circ J. 2018 Apr 25;82(5):1451-1458. doi: 10.1253/circj.CJ-17-1334. Epub 2018 Mar 16.
5
Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.三尖瓣和二尖瓣联合修复与单纯二尖瓣修复治疗重度 MR 和 TR:来自 TriValve 和 TRAMI 注册研究的分析。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):543-550. doi: 10.1016/j.jcin.2019.10.023. Epub 2020 Jan 15.
6
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis.心脏淀粉样变性患者中单纯或合并中重度二尖瓣和三尖瓣反流的患病率和临床转归。
Eur Heart J Cardiovasc Imaging. 2024 Jun 28;25(7):1007-1017. doi: 10.1093/ehjci/jeae060.
7
Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction.左心室收缩功能障碍患者中二尖瓣反流和三尖瓣反流的预后意义
Am Heart J. 2002 Sep;144(3):524-9. doi: 10.1067/mhj.2002.123575.
8
Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction.三尖瓣反流与射血分数降低的心力衰竭患者的临床结局。
JACC Heart Fail. 2024 Mar;12(3):552-563. doi: 10.1016/j.jchf.2023.11.018. Epub 2024 Jan 31.
9
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure.三尖瓣反流与急性心力衰竭结局的关系。
Circ Cardiovasc Imaging. 2023 Jul;16(7):566-576. doi: 10.1161/CIRCIMAGING.122.014988. Epub 2023 Jun 29.
10
Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.三尖瓣反流对临床结局的影响:COAPT 试验。
J Am Coll Cardiol. 2020 Sep 15;76(11):1305-1314. doi: 10.1016/j.jacc.2020.07.035.

引用本文的文献

1
Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop.优化用于监管决策的患者登记系统——来自HMA/EMA多利益相关方研讨会的关键经验教训
Clin Pharmacol Ther. 2025 Sep;118(3):551-560. doi: 10.1002/cpt.3733. Epub 2025 Jun 2.
2
Clinical Characteristics, Outcomes, and Risk Stratification of Combined Mitral and Tricuspid Regurgitation: The China-VHD Study.二尖瓣和三尖瓣反流合并症的临床特征、结局及风险分层:中国瓣膜性心脏病研究
JACC Asia. 2025 Mar;5(3 Pt 2):436-452. doi: 10.1016/j.jacasi.2024.07.009. Epub 2024 Sep 10.
3
Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair.
二尖瓣经导管缘对缘修复术中的三尖瓣反流及其结局
Eur Heart J. 2025 Apr 15;46(15):1415-1427. doi: 10.1093/eurheartj/ehae924.
4
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
5
Atrial Functional Mitral Regurgitation: Definition, Mechanisms, and Treatment Perspectives.心房功能性二尖瓣反流:定义、机制及治疗展望
Curr Cardiol Rep. 2025 Jan 11;27(1):16. doi: 10.1007/s11886-024-02188-2.
6
Multimodality Imaging for Transcatheter Tricuspid Regurgitation Interventions: Novel Approaches to the Forgotten Valve.经导管三尖瓣反流介入治疗的多模态影像学:被遗忘瓣膜的新方法。
Echocardiography. 2024 Dec;41(12):e70044. doi: 10.1111/echo.70044.
7
Sex-Specific Insights into Etiology, Diagnosis, Treatment, and Prognosis in Significant Tricuspid Regurgitation: A Narrative Review.重度三尖瓣反流病因、诊断、治疗及预后的性别特异性见解:一篇叙述性综述
Biomedicines. 2024 Oct 3;12(10):2249. doi: 10.3390/biomedicines12102249.
8
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.欧洲心力衰竭:在慢性和急性、既往存在和新发的射血分数降低、轻度降低和保留的心力衰竭中,遵循指南的药物治疗应用及决策制定——欧洲心脏病学会(ESC)欧洲心力衰竭调查研究项目(EORP)心力衰竭III注册研究
Eur J Heart Fail. 2024 Dec;26(12):2487-2501. doi: 10.1002/ejhf.3445. Epub 2024 Sep 10.
9
Heart failure with preserved ejection fraction.射血分数保留的心力衰竭。
Nat Rev Dis Primers. 2024 Aug 14;10(1):55. doi: 10.1038/s41572-024-00540-y.
10
2024 update in heart failure.2024年心力衰竭治疗进展
ESC Heart Fail. 2025 Feb;12(1):8-42. doi: 10.1002/ehf2.14857. Epub 2024 May 28.